The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...

More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

The lawsuit accuses drug manufacturer Novo Nordisk of failing to warn patients of the possible association between the popular drug and an eye condition called NAION.

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Novo Nordisk is accused in a suit of failing to warn that weight loss drug Ozempic could cause blindness. The plaintiff, a Maryland man, claims he developed non-arteritic anterior ischemic optic ...

The lawsuits allege that Ozempic causes a rare eye condition called NAION, or non-arteritic anterior ischemic optic neuropathy, which is akin to an eye stroke. All but one of the cases were filed ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.

Ozempic was originally approved by the Food and Drug Administration (FDA) to treat people with Type 2 diabetes, who risk ...